ArticleJournal of clinical laboratory analysis2020

CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53.

Kaitai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.